News
Dr Hurwitz on the Feasibility of Utilizing CAR T-Cell Therapy in Solid Tumors
Michael Hurwitz, MD, PhD, associate professor, Internal Medicine (Medical Oncology), Yale School of Medicine, discusses the feasibility of utilizing CAR T-cell therapies in patients with solid tumors, such as kidney cancers.
Source: OncLive